BA — The Boeing Company

Wall Street is broadly constructive—38 Buy ratings vs. 12 Hold and 5 Sell, with a consensus target of $274.29—but the price tape is weak: as of 2026-08-27 the stock is below all major moving averages and RSI is 37.36. The 737-7 certification and Q2 2026 positive FCF are real positives, yet they are being offset by near-zero operating margins, defense charges, and the August 21 SPEEA contract rejection that raises strike risk.

Revenue has inflected sharply upward from the 2024 trough: Q2 2026 revenue of $24.56B was the highest in the three-year window, up 8.0% YoY and roughly 45% above Q2 2024's $16.87B. Operating income, however, is still only marginally positive—$78M in Q2 2026 and $448M in Q1 2026—and the large swings in 2024–2025 were mostly charges and one-offs: Q3 2025 had a -$4.79B operating loss, and Q4 2025 reported +$8.22B net income on a gain, not core operations. TTM FCF through Q2 2026 is still roughly -$1.6B, though the quarterly trajectory improved to +$449M in Q3 2025 and +$631M in Q2 2026. This is a cyclical recovery in revenue and deliveries, but sustained profitability has not yet been established.

Fair, not cheap. Trailing P/S of 1.77 is slightly below the 5-year average of 1.84, and forward P/S is about 1.69 on consensus FY2026 revenue of $98.1B. But the trailing P/E of 78.6 is a statistical fluke from the one-off Q4 2025 gain, and the Street still models a small FY2026 EPS loss of -$0.99, so there is no reliable earnings multiple to anchor to. P/B of 27.2 reflects a tiny $6.1B equity base after years of losses, not inexpensive valuation.

At $209.89 as of 2026-08-27, the market is paying close to a normal historical sales multiple for a company whose earnings are still depressed—essentially pricing in a successful turnaround before the P&L has confirmed it. If the 737/787 ramp and FCF recovery continue, this will look like a reasonable early-cycle price. If a strike or another program charge hits, estimates move down and the stock could test the $176.77 52-week low. The earnings playbook is 'show-me': the stock needs margins and FCF to catch up to revenue, not just delivery headlines.

As of 2026-08-27, RSI(14) was 37.36—weak but not oversold—and price was -6.65% below its 20-day, -4.94% below its 50-day, and -4.51% below its 200-day SMA. That is a short-term downtrend/range-bound setup, not a capitulation bottom. The key support is the lower end of the 52-week range near $177; a reclaim of the 20-day would be the first early-entry signal.

• Labor: SPEEA contract expires October 6, 2026; 17,000 engineers voted down the offer, creating a strike threat that could disrupt certification and delivery plans.
• Supply chain/production ramp: Boeing is targeting 737 rates of 47–52/month, but management still guides only $1–3B of FY2026 FCF, showing output is not yet converting to cash efficiently.
• Interest rates/credit: Long-term debt stands at $41.3B against just $6.1B of equity, so higher-for-longer rates raise refinancing and carrying-cost risk.
• Defense budget/F-15 IDIQ: The $131.2B contract ceiling is headline-grabbing, but only ~$344K was initially funded; defense margins remain pressured by fixed-price losses like VC-25B.
• Regulatory/competitive: FAA certification of the 737-7 removes a major overhang, but Airbus continues to lead deliveries, keeping commercial pricing pressure on Boeing.

• SPEEA contract resolution around October 6, 2026—avoiding a strike would remove a major overhang; a strike would halt critical engineering and certification work.
• Q3 2026 earnings in late October: updated FCF, 737/787 delivery rates, and any new defense charges will set the tone.
• Continued 737 rate ramp to 47–52/month and potential 787 production increases.
• Funded task orders under the F-15 IDIQ contract, which would convert the headline ceiling into actual revenue.
• Completion of the Archer Aviation/AAM divestitures, which could simplify the portfolio and improve focus on core commercial/defense programs.

• A SPEEA strike beginning October 6, 2026 would disrupt certification, engineering, and deliveries.
• Persistent negative TTM FCF and high leverage ($41.3B LT debt, D/E 7.5) leave limited financial cushion.
• Additional defense fixed-price program charges (e.g., VC-25B) could push operating results back into large losses.
• Production ramp failures, quality lapses, or certification setbacks on 737/787 programs.
• Continued commercial market share losses to Airbus, which limits pricing power as Boeing recovers.

Boeing is a legitimate recovery story—revenue is at multi-year highs, Q2 2026 FCF was positive, the 737-7 is certified, and debt has come down from peak levels. But margins are still near zero, TTM FCF is negative, and the SPEEA strike threat makes the next 60 days a binary event. At $209.89, the risk/reward is balanced rather than a standout buy; I would want either a better price near $177 support or confirmation of sustained positive FCF and margin expansion.

I valued BA by applying a 1.80x forward revenue multiple to consensus FY2026 revenue of $98.1B—a slight discount to Boeing's 5-year average P/S of 1.84 to reflect negative TTM FCF, thin equity, and strike risk—and divided by roughly 790M shares implied by the current market cap/price, yielding approximately $223.45.